Updated

US FDA panel backs restricted use of AstraZeneca’s prostate cancer drug

(Corrects typo in headline to read “prostate”, not “prostrate”) (Reuters) -A panel of U.S. Food and Drug Administration advisers on Friday voted for the restricted use of British drugmaker AztraZeneca Plc’s experimental treatment, jointly developed with Merck & Co, for a type of prostate cancer. The FDA panel voted 11-1 with one abstention, in favor …

US FDA panel backs restricted use of AstraZeneca’s prostate cancer drug Read More »

FDIC prepares to place First Republic under receivership

By Greg Roumeliotis NEW YORK (Reuters) – The U.S. Federal Deposit Insurance Corporation (FDIC) is preparing to place First Republic Bank under receivership imminently, a person familiar with the matter said on Friday, sending shares of the lender down nearly 50% in extended trading.     The U.S. banking regulator decided the troubled regional lender’s position …

FDIC prepares to place First Republic under receivership Read More »

Behind EU lawmakers’ challenge to rein in ChatGPT and generative AI

(This April 28 story has been refiled to remove repeated word in paragraph 1) By Martin Coulter and Supantha Mukherjee LONDON/STOCKHOLM (Reuters) – As recently as February, generative AI did not feature prominently in EU lawmakers’ plans for regulating artificial intelligence technologies such as ChatGPT. The bloc’s 108-page proposal for the AI Act, published two …

Behind EU lawmakers’ challenge to rein in ChatGPT and generative AI Read More »

Japan PM Kishida to visit South Korea for summit with Yoon – sources

By Kevin Buckland TOKYO (Reuters) -Japanese Prime Minister Fumio Kishida is expected to visit South Korea in coming weeks and meet with President Yoon Suk Yeol, officials said, reciprocating a Tokyo visit by the South Korean leader last month. A Japanese government official and another official from a Group of Seven government said the meeting …

Japan PM Kishida to visit South Korea for summit with Yoon – sources Read More »